Genetic variability in <it>CYP3A4 </it>and <it>CYP3A5 </it>in primary liver, gastric and colorectal cancer patients
<p>Abstract</p> <p>Background</p> <p>Drug-metabolizing enzymes play a role in chemical carcinogenesis through enzymatic activation of procarcinogens to biologically reactive metabolites. The role of gene polymorphisms of several cytochrome P450 enzymes in digestive canc...
Main Authors: | García Monserrat, Martínez Carmen, Sastre Javier, Pizarro Rosa, Ladero José M, García-Martín Elena, Gervasini Guillermo, Diaz-Rubio Manuel, Agúndez José AG |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-07-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/7/118 |
Similar Items
-
Polymorphisms in the cytochrome <it>P</it>450 genes <it>CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1</it>, <it>CYP19A1 </it>and colorectal cancer risk
by: Withey Laura, et al.
Published: (2007-07-01) -
Analysis of the functional polymorphism in the cytochrome P450 CYP2C8 gene rs11572080 with regard to colorectal cancer risk
by: José M Ladero, et al.
Published: (2012-12-01) -
Propoxyphene, Norpropoxyphene, and Proadifen (SKF-525A) Are Mechanism Based Inhibitors of CYP3A4, CYP3A5, and CYP3A in Human Liver Microsomes
by: Riley, Anna Ruth
Published: (2008) -
<it>CYP3A4 </it>and <it>CYP3A5 </it>genotyping by Pyrosequencing
by: McLeod Howard L, et al.
Published: (2005-05-01) -
CYP3A and CYP2C19 activity in urine in relation to CYP3A4, CYP3A5, and CYP2C19 polymorphisms in Russian peptic ulcer patients taking omeprazole
by: Denisenko NP, et al.
Published: (2018-06-01)